Panbela Therapeutics, Inc. (PBLA)
Largest Insider Buys in Sector
PBLA Stock Price History Chart
PBLA Stock Performance
About Panbela Therapeutics, Inc.
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, which is in Phase Ia/Ib clinical trial for the treatment of patients with metastatic pancreatic …
Insider Activity of Panbela Therapeutics, Inc.
Over the last 12 months, insiders at Panbela Therapeutics, Inc. have bought $0 and sold $0 worth of Panbela Therapeutics, Inc. stock.
On average, over the past 5 years, insiders at Panbela Therapeutics, Inc. have bought $82,238 and sold $51,741 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 4,444 shares for transaction amount of $9,999 was made by Horvath Susan (V.P. of Finance & CFO) on 2023‑01‑30.
List of Insider Buy and Sell Transactions, Panbela Therapeutics, Inc.
| 2023-11-08 | Sale | 10 percent owner | 72,874 2.525% | $0.71 | $51,741 | -96.79% | ||
| 2023-01-30 | V.P. of Finance & CFO | 4,444 0.0836% | $2.25 | $9,999 | -95.86% | |||
| 2023-01-30 | President and CEO | 4,444 0.0836% | $2.25 | $9,999 | -95.86% | |||
| 2022-10-04 | director | 200,000 – | $0 | $0 | -95.25% | |||
| 2022-10-04 | director | 165,000 – | $0 | $0 | -95.25% | |||
| 2022-10-04 | director | 33,000 – | $0 | $0 | -95.25% | |||
| 2020-09-10 | President and CEO | 1,000 0.0121% | $2.74 | $2,737 | +32.40% | |||
| 2020-09-08 | director | 225 0.0029% | $2.55 | $574 | +51.39% | |||
| 2020-09-04 | director | 24,775 0.3066% | $2.51 | $62,158 | +47.86% | |||
| 2020-09-01 | Exec. Chairman, Pres. & CEO | 10,000 0.1895% | $4.13 | $41,250 | +37.68% | |||
| 2020-09-01 | V.P. of Finance & CFO | 2,424 0.0459% | $4.13 | $9,999 | +37.68% | |||
| 2020-09-01 | President and CEO | 2,424 0.0459% | $4.13 | $9,999 | +37.68% | |||
| 2020-09-01 | director | 2,424 0.0459% | $4.13 | $9,999 | +37.68% | |||
| 2020-06-05 | director | 10,000 0.1238% | $4.00 | $40,000 | -16.25% | |||
| 2020-06-05 | V.P. of Finance & CFO | 2,500 0.0309% | $4.00 | $10,000 | -16.25% | |||
| 2020-05-22 | Exec. Chairman, Pres. & CEO | 10,000 0.1143% | $4.00 | $40,000 | -23.08% |